-
1
-
-
0032941959
-
Effects of erythropoietin administration in training athletes and possible indirect detection in doping control
-
Audran M, Gareau R, Matecki S. Effects of erythropoietin administration in training athletes and possible indirect detection in doping control. Medicine and Science of Sports and Exercise. 31:1999;639-645.
-
(1999)
Medicine and Science of Sports and Exercise
, vol.31
, pp. 639-645
-
-
Audran, M.1
Gareau, R.2
Matecki, S.3
-
2
-
-
0033007019
-
Peptide hormones abuse in sport: State of the art in the detection of growth hormone and erythropoietin
-
Rivier R, Saugy M. Peptide hormones abuse in sport: state of the art in the detection of growth hormone and erythropoietin. Journal of Toxicology and Toxin Reviews. 18:1999;145-176.
-
(1999)
Journal of Toxicology and Toxin Reviews
, vol.18
, pp. 145-176
-
-
Rivier, R.1
Saugy, M.2
-
3
-
-
0343891640
-
Growth factors and control of haematopoiesis
-
R. Hoffmann, E. Benz, S. Shattil, B. Furie, & H. Cohen. New York: Churchill Livingstone
-
Bagby G, Segal G. Growth factors and control of haematopoiesis. Hoffmann R, Benz E, Shattil S, Furie B, Cohen H. Hematology: Basic Principles and Practice. 1991;97-121 Churchill Livingstone, New York.
-
(1991)
Hematology: Basic Principles and Practice
, pp. 97-121
-
-
Bagby, G.1
Segal, G.2
-
4
-
-
0343455905
-
Pharmacologic alternatives to blood transfusion
-
R. Hoffmann, E. Benz, S. Shattil, B. Furie, & H. Cohen. New York: Churchill Livingstone
-
Goodnough L. Pharmacologic alternatives to blood transfusion. Hoffmann R, Benz E, Shattil S, Furie B, Cohen H. Hematology: Basic Principles and Practice. 1991;1665-1669 Churchill Livingstone, New York.
-
(1991)
Hematology: Basic Principles and Practice
, pp. 1665-1669
-
-
Goodnough, L.1
-
5
-
-
0022484262
-
Characterization and biological effects of recombinant human erythropoietin
-
Egrie J C, Strickland T W, Lane J. Characterization and biological effects of recombinant human erythropoietin. Immunobiology. 172:1986;213-224.
-
(1986)
Immunobiology
, vol.172
, pp. 213-224
-
-
Egrie, J.C.1
Strickland, T.W.2
Lane, J.3
-
7
-
-
0026512123
-
Detection of functional iron deficiency during erythropoietin treatment: A new approach
-
McDougall I C, Cavill I, Hulme B. Detection of functional iron deficiency during erythropoietin treatment: a new approach. British Medical Journal. 304:1992;225-226.
-
(1992)
British Medical Journal
, vol.304
, pp. 225-226
-
-
McDougall, I.C.1
Cavill, I.2
Hulme, B.3
-
8
-
-
0028438939
-
Effects of subcutaneous recombinant human erythropoietin in normal subjects: Development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis
-
Brugnara C, Colella G M, Cremins J. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis. Journal of Laboratory and Clinical Medicine. 123:1994;660-667.
-
(1994)
Journal of Laboratory and Clinical Medicine
, vol.123
, pp. 660-667
-
-
Brugnara, C.1
Colella, G.M.2
Cremins, J.3
-
9
-
-
0030071458
-
Optimal timing of repeated recombinant human erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers
-
Breymann C, Bauer C, Major A. Optimal timing of repeated recombinant human erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers. British Journal of Haematology. 92:1996;295-301.
-
(1996)
British Journal of Haematology
, vol.92
, pp. 295-301
-
-
Breymann, C.1
Bauer, C.2
Major, A.3
-
11
-
-
0019992506
-
Diurnal variation of serum immunoreactive erythropoietin in a normal subject
-
Cotes P M, Brozovic B. Diurnal variation of serum immunoreactive erythropoietin in a normal subject. Clinical Endocrinology. 17:1982;419-422.
-
(1982)
Clinical Endocrinology
, vol.17
, pp. 419-422
-
-
Cotes, P.M.1
Brozovic, B.2
-
12
-
-
0025967383
-
Bestimmung der Erythropoietin-Aktivät im Serum. Methodik, Indikation und Interpretation der Messdaten
-
Jelkmann W, Wolff M. Bestimmung der Erythropoietin-Aktivät im Serum. Methodik, Indikation und Interpretation der Messdaten. Deutsche Medizinische Wochenschrift. 116:1991;230-234.
-
(1991)
Deutsche Medizinische Wochenschrift
, vol.116
, pp. 230-234
-
-
Jelkmann, W.1
Wolff, M.2
-
13
-
-
0343020305
-
Erythrocytosis
-
R. Hoffmann, R. Benz, S. Shattil, B. Furie, & H. Cohen. New York: Churchill Livingstone
-
Spivak J. Erythrocytosis. Hoffmann R, Benz R, Shattil S, Furie B, Cohen H. Hematology: Basic Principles and Practice. 1991;319-326 Churchill Livingstone, New York.
-
(1991)
Hematology: Basic Principles and Practice
, pp. 319-326
-
-
Spivak, J.1
-
14
-
-
0023911237
-
The heterogeneity of circulating human serum erythropoietin
-
Sherwood J B, Carmichael L D, Goldwasser E. The heterogeneity of circulating human serum erythropoietin. Endocrinology. 122:1988;1472-1477.
-
(1988)
Endocrinology
, vol.122
, pp. 1472-1477
-
-
Sherwood, J.B.1
Carmichael, L.D.2
Goldwasser, E.3
-
15
-
-
0028401651
-
The molecular physiology of erythropoietin and the erythropoietin receptor
-
Zhu Y, D'Andrea A D. The molecular physiology of erythropoietin and the erythropoietin receptor. Current Opinion in Hematology. 1:1994;113-118.
-
(1994)
Current Opinion in Hematology
, vol.1
, pp. 113-118
-
-
Zhu, Y.1
D'Andrea, A.D.2
-
17
-
-
0028859515
-
Application of a modified INCSTAR EPO-trac 125/RIA for measurement of serum erythropoietin concentration in elite athletes
-
Roberts D, Schuh D, Smith D J. Application of a modified INCSTAR EPO-trac 125/RIA for measurement of serum erythropoietin concentration in elite athletes. Clinical Biochemistry. 28:1995;573-580.
-
(1995)
Clinical Biochemistry
, vol.28
, pp. 573-580
-
-
Roberts, D.1
Schuh, D.2
Smith, D.J.3
-
19
-
-
0029813724
-
Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and doping control
-
Souillard A, Audran M, Bressolle F. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and doping control. British Journal of Clinical Pharmacology. 42:1996;355-364.
-
(1996)
British Journal of Clinical Pharmacology
, vol.42
, pp. 355-364
-
-
Souillard, A.1
Audran, M.2
Bressolle, F.3
-
20
-
-
0025123840
-
Molecular charge heterogeneity of human serum EPO
-
Wide L, Bengtsson C. Molecular charge heterogeneity of human serum EPO. British Journal of Haematology. 76:1990;121-127.
-
(1990)
British Journal of Haematology
, vol.76
, pp. 121-127
-
-
Wide, L.1
Bengtsson, C.2
-
22
-
-
0032576401
-
What is a normal red-blood cell mass for professional cyclists?
-
Saris W, Senden J, Brouns F. What is a normal red-blood cell mass for professional cyclists? Lancet. 352:1998;1758.
-
(1998)
Lancet
, vol.352
, pp. 1758
-
-
Saris, W.1
Senden, J.2
Brouns, F.3
-
23
-
-
0032497140
-
Packed cell volume in elite athletes
-
Marx J J, Vergouwen P C. Packed cell volume in elite athletes. Lancet. 352:1998;451.
-
(1998)
Lancet
, vol.352
, pp. 451
-
-
Marx, J.J.1
Vergouwen, P.C.2
-
24
-
-
0033007485
-
Erythropoietin concentration and arterial haemoglobin saturation with supramaximal exercise
-
Roberts D, Smith D J. Erythropoietin concentration and arterial haemoglobin saturation with supramaximal exercise. Journal of Sports Sciences. 17:1999;485-493.
-
(1999)
Journal of Sports Sciences
, vol.17
, pp. 485-493
-
-
Roberts, D.1
Smith, D.J.2
-
27
-
-
0034071563
-
'Blood doping' with rhEPO and assessment of functional iron deficiency in healthy volunteers
-
Breymann C, Rohling R, Krafft A. 'Blood doping' with rhEPO and assessment of functional iron deficiency in healthy volunteers. British Journal of Haematology. 108:2000;883.
-
(2000)
British Journal of Haematology
, vol.108
, pp. 883
-
-
Breymann, C.1
Rohling, R.2
Krafft, A.3
-
28
-
-
0030825066
-
Population pharmacodynamics for monitoring epoietin abuse in athletes
-
Bressolle F, Audran M, Guidicelli C. Population pharmacodynamics for monitoring epoietin abuse in athletes. Clinical Drug Investigation. 14:1997;233-242.
-
(1997)
Clinical Drug Investigation
, vol.14
, pp. 233-242
-
-
Bressolle, F.1
Audran, M.2
Guidicelli, C.3
-
31
-
-
0031442094
-
Comparison of a direct and indirect population pharmacodynamic model: Application to recombinant human erythropoietin in athletes
-
Bressolle F, Audran M, Gareau R. Comparison of a direct and indirect population pharmacodynamic model: application to recombinant human erythropoietin in athletes. Journal of Pharmacokinetics and Biopharmaceutics. 25:1997;263-275.
-
(1997)
Journal of Pharmacokinetics and Biopharmaceutics
, vol.25
, pp. 263-275
-
-
Bressolle, F.1
Audran, M.2
Gareau, R.3
-
32
-
-
0029131778
-
Total fibrin and fibrinogen degradation products in urine: A possible probe to detect illicit users of the physical-performance enhancer erythropoietin?
-
Gareau R, Brisson G R, Chenard C. Total fibrin and fibrinogen degradation products in urine: a possible probe to detect illicit users of the physical-performance enhancer erythropoietin? Hormone Research. 44:1995;189-192.
-
(1995)
Hormone Research
, vol.44
, pp. 189-192
-
-
Gareau, R.1
Brisson, G.R.2
Chenard, C.3
-
33
-
-
0032994109
-
Effects of iron supplementation on total body hemoglobin during endurance training at moderate altitude
-
Friedmann B, Jost J, Rating T. Effects of iron supplementation on total body hemoglobin during endurance training at moderate altitude. International Journal of Sports Medicine. 20:1999;78-85.
-
(1999)
International Journal of Sports Medicine
, vol.20
, pp. 78-85
-
-
Friedmann, B.1
Jost, J.2
Rating, T.3
|